Clinical study of electro-acupuncture treatment with different intensities for functional constipation patients

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 34, Issue 5, 2014, Pages 775-781

  Xiong, Fan ^a   Wang, Ying ^a   Li, Shi qi ^a   Tian, Man ^a   Zheng, Cui hong ^a   Huang, Guang ying ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

current intensity; electro acupuncture; functional constipation; quchi (LI11); shangjuxu (ST37)

Indexed keywords

HYDROCORTISONE; SUBSTANCE P; VASOACTIVE INTESTINAL POLYPEPTIDE;

ACUPUNCTURE; ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; ANXIETY; BLOOD; CONSTIPATION; CONTROLLED STUDY; DEFECATION; DEPRESSION; ELECTROACUPUNCTURE; FEMALE; HUMAN; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; STATISTICS AND NUMERICAL DATA; TIME; TREATMENT OUTCOME; YOUNG ADULT;

ACUPUNCTURE POINTS; ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; ANXIETY; CONSTIPATION; DEFECATION; DEPRESSION; ELECTROACUPUNCTURE; FEMALE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); SUBSTANCE P; TIME FACTORS; TREATMENT OUTCOME; VASOACTIVE INTESTINAL PEPTIDE; YOUNG ADULT;

EID: 84919644160     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-014-1351-8     Document Type: Article

References (46)

1. Dennison C, Prasad M, Lloyd A, et al. The health-related quality of life and economic burden of constipation. Pharmacoeconomics, 2005, 23(5):461–476
2. Longstreth GF, Thompson WG, Chey WD, et al. Functional bowel disorders. Gastroenterology, 2006, 130(5): 1480–1491
3. Sun SX, Dibonaventura M, Purayidathil FW, et al. Impact of chronic constipation on health-related quality of life, work productivity, and healthcare resource use: an analysis of the national health and wellness survey. Dig Dis Sci, 2011, 56(9):2688–2695
4. Higgins PD, Johanson JF. Epidemiology of constipation in North America: a systematic review. Am J Gastroenterol, 2004, 99(4):750–759
5. Riezzo G, Orlando A, D’Attoma B, et al. Randomised clinical trial: efficacy of Lactobacillus paracasei-enriched artichokes in the treatment of patients with functional constipation-a double-blind, controlled, crossover study. Aliment Pharmacol Ther, 2012, 35(4):441–450
6. Ford AC, Suares NC. Effect of laxatives and pharmacological therapies in chronic idiopathic constipation: systematic review and meta-analysis. Gut, 2011, 60(2):209–218
7. Dong Z, Sun Y, Lu P, et al. Electroacupuncture and lumbar transplant of GDNF-secreting fibroblasts synergistically attenuate hyperalgesia after sciatic nerve constriction. Am J Chin Med, 2013, 41(3):459–472
8. Napadow V, Makris N, Liu J, et al. Effects of electroacupuncture versus manual acupuncture on the human brain as measured by fMRI. Hum Brain Mapp, 2005, 24(3):193–205
9. Li M, Peng J, Song Y, et al. Electro-acupuncture combined with transcranial magnetic stimulation improves learning and memory function of rats with cerebral infarction by inhibiting neuron cell apoptosis. J Huazhong Univ Sci Technolog Med Sci, 2012, 32(5):746–749
10. Zeng Q, Li M, Ouyang X, et al. Effect of electroacupuncture on reperfusion ventricular arrhythmia in rat. J Huazhong Univ Sci Technolog Med Sci, 2006, 26(3):269–271
11. Zhao L, Shi J, Sun N, et al. Effect of electroacupuncture on TRPM7 mRNA expression after cerebral ischemia/reperfusion in rats via TrkA pathway. J Huazhong Univ Sci Technolog Med Sci, 2005, 25(3):247–250
12. Ouyang H, Chen JD. Review article: therapeutic roles of acupuncture in functional gastrointestinal disorders. Aliment Pharmacol Ther, 2004, 20(8):831–841
13. Broide E, Pintov S, Portnoy S, et al. Effectiveness of acupuncture for treatment of childhood constipation. Dig Dis Sci, 2001, 46(6):1270–1275
14. Chesterton LS, Foster NE, Wright CC, et al. Effects of TENS frequency, intensity and stimulation site parameter manipulation on pressure pain thresholds in healthy human subjects. Pain, 2003, 106(1–2):73–80
15. Bjordal JM, Johnson MI, Ljunggreen AE. Transcutaneous electrical nerve stimulation (TENS) can reduce postoperative analgesic consumption: a meta-analysis with assessment of optimal treatment parameters for postoperative pain. Eur J Pain, 2003, 7(2):181–188
16. Olsén MF, Elden H, Janson ED, et al. A comparison of high-versus low-intensity, high-frequency transcutaneous electric nerve stimulation for painful postpartum uterine contractions. Acta Obstet Gynecol Scand, 2007, 86(3):310–314
17. Barlas P, Ting SL, Chesterton LS, et al. Effects of intensity of electroacupuncture upon experimental pain in healthy human volunteers: A randomized, double-blind, placebo-controlled study. Pain, 2006, 122(1–2):81–89
18. Li Y, Zheng H, Zeng F, et al. Use acupuncture to treat functional constipation: study protocol for a randomized controlled trial. Trials, 2012, 13:104–111
19. Baxter GS, Craig DA, Clarke DE. 5-Hydroxytryptamine4 receptors mediate relaxation of the rat oesophageal tunica muscularis mucosae. Naunyn Schmiedebergs Arch Pharmacol, 1991, 343(5):439–446
20. Mader R, Kocher T, Haier J, et al. Investigation of serotonin type 4 receptor expression in human and non-human primate gastrointestinal samples. Eur J Gastroenterol Hepatol, 2006, 18(9):945–950
21. McLean PG, Coupar IM. Stimulation of cyclic AMP formation in the circular smooth muscle of human colon by activation of 5-HT4-like receptors. Br J Pharmacol, 1996, 117(2):238–239
22. Sakurai-Yamashita Y, Yamashita K, Yoshimura M, et al. Differential localization of 5-hydroxytryptamine3 and 5-hydroxytryptamine4 receptors in the human rectum. Life Sci, 2000, 66(1):31–34
23. Sun Y, Li XY, Yao LY, et al. Investigation of attention via the counting Stroop task in patients with functional constipation. Chin Med J, 2012, 125(3):486–490
24. Merkel IS, Locher J, Burgio K, et al. Physiologic and psychologic characteristics of an elderly population with chronic constipation. Am J Gastroenterol, 1993, 88(11): 1854–1859
25. Gue M, Junien JL, Bueno L. Conditioned emotional response in rats enhances colonic motility through the central release of corticotropin-releasing factor. Gastroenterology, 1991, 100(4):964–970
26. Chattat R, Bazzocchi G, Balloni M, et al. Illness behavior, affective disturbance and intestinal transit time in idiopathic constipation. J Psychosom Res, 1997, 42(1):95–100
27. Brummett BH, Kuhn CM, Boyle SH, et al. Cortisol responses to emotional stress in men: association with a functional polymorphism in the 5HTR2C gene. Biol Psychol, 2012, 89(1):94–98
28. Rosmond R. Role of stress in the pathogenesis of the metabolic syndrome. Psychoneuroendocrinology, 2005, 30(1): 1–10
29. Kim JG, Jung HS, Kim KJ, et al. Basal blood corticosterone level is correlated with susceptibility to chronic restraint stress in mice. Neurosci Lett, 2013, 555:137–142
30. Kumari M, Badrick E, Sacker A, et al. Identifying patterns in cortisol secretion in an older population. Findings from the Whitehall II study. Psychoneuroendocrinology, 2010, 35(7):1091–1099
31. Hamer M, Endrighi R, Venuraju SM, et al. Cortisol responses to mental stress and the progression of coronary artery calcification in healthy men and women. PLoS One, 2012, 7(2):e31356
32. Gong S, Ding J, Chang Q. The expression of VIP and SP in the cochlea of spontaneously hypertensive rats and its implication. J Huazhong Univ Sci Technolog Med Sci, 2004, 24(4):396–399
33. Datar P, Srivastava S, Coutinho E, et al. Substance P: structure, function, and therapeutics. Curr Top Med Chem, 2004, 4(1):75–103
34. De Felipe C, Herrero JF, O’Brien JA, et al. Altered nociception, analgesia and aggression in mice lacking the receptor for substance P. Nature, 1998, 392(6674):394–397
35. Ebner K, Singewald N. The role of substance P in stress and anxiety responses. Amino Acids, 2006, 31(3):251–272
36. Hutson JM, Chow CW, Hurley MR, et al. Deficiency of substance P-immunoreactive nerve fibres in children with intractable constipation: a form of intestinal neuronal dysplasia. J Paediatr Child Health, 1997, 33(3):187–189
37. Hutson JM, Chow CW, Borg J. Intractable constipation with a decrease in substance P-immunoreactive fibres: is it a variant of intestinal neuronal dysplasia? J Pediatr Surg, 1996, 31(4):580–583
38. Tomita R. Regulation of the peptidergic nerves (substance P and vasoactive intestinal peptide) in the colon of women patients with slow transit constipation: an in vitro study. Hepatogastroenterology, 2008, 55(82–83):500–507
39. Liu L, Shang F, Morgan MJ, et al. Cyclooxygenase-dependent alterations in substance P-mediated contractility and tachykinin NK1 receptor expression in the colonic circular muscle of patients with slow transit constipation. J Pharmacol Exp Ther, 2009, 329(1):282–289
40. King SK, Sutcliffe JR, Ong SY, et al. Substance P and vasoactive intestinal peptide are reduced in right transverse colon in pediatric slow-transit constipation. Neurogastroenterol Motil, 2010, 22(8):883–892
41. Said SI, Mutt V. Polypeptide with broad biological activity: isolation from small intestine. Science, 1970, 169(3951): 1217–1218
42. Said SI, Mutt V. Potent peripheral and splanchnic vasodilator peptide from normal gut. Nature, 1970, 225(5235): 863–864
43. Qiao Y, Fang JG, Xiao J, et al. Effect of baicalein on the expression of VIP in extravillous cytotrophoblasts infected with human cytomegalovirus in vitro. J Huazhong Univ Sci Technolog Med Sci, 2013, 33(3):406–411
44. Cortesini C, Cianchi F, Infantino A, et al. Nitric oxide synthase and VIP distribution in enteric nervous system in idiopathic chronic constipation. Dig Dis Sci, 1995, 40(11):2450–2455
45. Han B. Correlation between gastrointestinal hormones and anxiety-depressive states in irritable bowel syndrome. Ther Med, 2013, 6(3):715–720
46. Shen GM, Zhou MQ, Xu GS, et al. Role of vasoactive intestinal peptide and nitric oxide in the modulation of electroacupucture on gastric motility in stressed rats. World J Gastroenterol, 2006, 12(38):6156–6160